Login to Your Account


Bird's-eye view of cost of cancer therapies may shortchange patients

By Marie Powers
Staff Writer

Friday, June 27, 2014
SAN DIEGO – What's the value equation for the cost of cancer therapy, and what portion of that cost should public and private payers bear? The topic – an important one for patients and drug developers alike – was the intriguing premise of a session on the final day of the BIO International Convention.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription